MyFinsight
Home
Blog
About
Valion Bio, Inc. (VBIO)
Valion Bio, Inc. (VBIO)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$5,338K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Amortization of debt discount an...
Depreciation
Accrued expenses
Others
Negative Cash Flow Breakdown
Net loss from continuing operati...
Lease liabilities
Offering costs in advance of sal...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
Net loss from continuing operations
-7,057
-6,225
Stock-based compensation
133
208
Depreciation
358
4
Amortization of debt discount and debt issuance costs
489
445
Non-cash interest expense
203
203
Change in fair value of derivative liability
47
33
Amortization of right-of-use asset
251
177
Prepaid expenses and other current assets
-163
341
Inventory
0
750
Other assets
4
86
Accounts payable
10
365
Accrued expenses
341
1,114
Lease liabilities
-114
-128
Net cash used in operating activities - continuing operations
-5,274
-5,047
Net cash provided by (used in) operating activities - discontinued operations
-7
36
Net cash used in operating activities
-5,281
-5,011
Acquisition of property and equipment
57
7
Acquisition of licensed technology
0
0
Net cash used in investing activities
-57
-7
Proceeds from issuance of common stock, net of issuance costs
69
-
Proceeds from issuance of preferred stock and common stock warrants, net of issuance costs
241
-
Proceeds from warrant exercises
-
0
Proceeds from warrant exercises, net of fees
-3
-
Offering costs in advance of sale of common stock
76
44
Net cash provided by financing activities
231
-44
Net decrease in cash and cash equivalents
-5,107
-5,062
Beginning of period
7,583
12,645
End of period
2,476
7,583
Less cash and cash equivalents included in discontinued operations
0
0
Cash and cash equivalents included in continuing operations
2,476
-
Cash and cash equivalents
2,108
-
Restricted cash
368
-
Total cash and cash equivalents included in continuing operations
2,476
7,583
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
preferred stock and common...
$241K
Proceeds from issuance of
common stock, net of...
$69K
Net cash provided by
financing activities
$231K
Canceled cashflow
$79K
Net decrease in cash
and cash...
-$5,107K
Canceled cashflow
$231K
Offering costs in advance
of sale of common...
$76K
Proceeds from warrant
exercises, net of fees
-$3K
Net cash used in
operating activities
-$5,281K
Net cash used in
investing activities
-$57K
Amortization of debt discount
and debt issuance...
$489K
Depreciation
$358K
Accrued expenses
$341K
Amortization of right-of-use
asset
$251K
Non-cash interest
expense
$203K
Prepaid expenses and
other current assets
-$163K
Stock-based compensation
$133K
Accounts payable
$10K
Net cash used in
operating activities -...
-$5,274K
Net cash provided by
(used in) operating...
-$7K
Canceled cashflow
$1,948K
Acquisition of property and
equipment
$57K
Net loss from
continuing operations
-$7,057K
Lease liabilities
-$114K
Change in fair value of
derivative liability
$47K
Other assets
$4K
Buy us a coffee